BNP Paribas Financial Markets’s Filana Therapeutics FLNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $502 | Sell |
422
-3
| -0.7% | -$4 | ﹤0.01% | 5680 |
|
|
2026
Q1 | $718 | Sell |
425
-10,584
| -96% | -$21.8K | ﹤0.01% | 5505 |
|
|
2025
Q4 | $21.8K | Sell |
11,009
-6,201
| -36% | -$19.9K | ﹤0.01% | 5000 |
|
|
2025
Q3 | $50.1K | Sell |
17,210
-73,691
| -81% | -$169K | ﹤0.01% | 4601 |
|
|
2025
Q2 | $165K | Buy |
90,901
+660
| +0.7% | +$1.17K | ﹤0.01% | 3846 |
|
|
2025
Q1 | $135K | Buy |
90,241
+25,680
| +40% | +$64.8K | ﹤0.01% | 3916 |
|
|
2024
Q4 | $152K | Buy |
64,561
+55,813
| +638% | +$980K | ﹤0.01% | 4007 |
|
|
2024
Q3 | $257K | Buy |
8,748
+5,250
| +150% | +$121K | ﹤0.01% | 3161 |
|
|
2024
Q2 | $43.2K | Sell |
3,498
-17,387
| -83% | -$367K | ﹤0.01% | 3482 |
|
|
2024
Q1 | $424K | Buy |
20,885
+1,786
| +9% | +$41.2K | ﹤0.01% | 2929 |
|
|
2023
Q4 | $430K | Sell |
19,099
-1,319
| -6% | -$27.9K | ﹤0.01% | 2876 |
|
|
2023
Q3 | $340K | Buy |
20,418
+9,973
| +95% | +$198K | ﹤0.01% | 2905 |
|
|
2023
Q2 | $256K | Sell |
10,445
-5,599
| -35% | -$135K | ﹤0.01% | 2922 |
|
|
2023
Q1 | $387K | Buy |
16,044
+10,383
| +183% | +$288K | ﹤0.01% | 2873 |
|
|
2022
Q4 | $167K | Sell |
5,661
-123,531
| -96% | -$4.44M | ﹤0.01% | 3067 |
|
|
2022
Q3 | $5.4M | Sell |
129,192
-92,073
| -42% | -$2.49M | 0.01% | 1334 |
|
|
2022
Q2 | $6.22M | Buy |
221,265
+217,805
| +6,295% | +$5.5M | 0.01% | 1135 |
|
|
2022
Q1 | $129K | Sell |
3,460
-17,094
| -83% | -$724K | ﹤0.01% | 3284 |
|
|
2021
Q4 | $898K | Buy |
20,554
+13,682
| +199% | +$717K | ﹤0.01% | 2662 |
|
|
2021
Q3 | $427K | Buy |
6,872
+5,405
| +368% | +$451K | ﹤0.01% | 2807 |
|
|
2021
Q2 | $125K | Sell |
1,467
-8,484
| -85% | -$454K | ﹤0.01% | 2979 |
|
|
2021
Q1 | $447K | Buy |
9,951
+3,776
| +61% | +$149K | ﹤0.01% | 2630 |
|
|
2020
Q4 | $42.1K | Sell |
6,175
-125
| -2% | -$1.12K | ﹤0.01% | 3632 |
|
|
2020
Q3 | $72.5K | Buy |
6,300
+5,432
| +626% | +$24.5K | ﹤0.01% | 3283 |
|
|
2020
Q2 | $2.67K | Buy |
+868
| New | +$3.94K | ﹤0.01% | 4153 |
|
|
2015
Q2 | – | Sell |
-132
| Closed | -$1.74K | – | 3609 |
|
|
2015
Q1 | $1.74K | Buy |
+132
| New | +$1.78K | ﹤0.01% | 3491 |
|
|
2014
Q4 | – | Sell |
-328
| Closed | -$8.98K | – | 2965 |
|
|
2014
Q3 | $8.98K | Buy |
328
+244
| +290% | +$7.41K | ﹤0.01% | 3643 |
|
|
2014
Q2 | $3.38K | Hold |
84
| – | – | ﹤0.01% | 2814 |
|
|
2014
Q1 | $3.35K | Hold |
84
| – | – | ﹤0.01% | 2520 |
|
|
2013
Q4 | $2.86K | Buy |
+84
| New | +$2.23K | ﹤0.01% | 3457 |
|
Other funds holding FLNA
GC
BNP Paribas Financial Markets's FLNA Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Filana Therapeutics (FLNA) stake by 0.71% in Q2 2026, selling an estimated $4 and leaving 422 shares worth $502. The position accounts for ﹤0.01% of the portfolio, ranked #5680.
BNP Paribas Financial Markets first reported a position in FLNA in Q4 2013 and has held it in 30 quarters since. The position peaked at $6.22M in Q2 2022. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.
- BNP Paribas Financial Markets held 422 shares of Filana Therapeutics worth $502 as of Q2 2026.
- BNP Paribas Financial Markets sold 3 Filana Therapeutics shares in Q2 2026, an estimated $4.
- Filana Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5680 holding.
- BNP Paribas Financial Markets first reported a position in Filana Therapeutics in Q4 2013 and has held it in 30 quarters since.
- BNP Paribas Financial Markets's Filana Therapeutics position peaked at $6.22M in Q2 2022.
- 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.